ERBB2 and cancer: Anti-HER2 ADCs were evaluated in vitro against HER2-expressing and non-expressing cancer cell lines: high-copy number HCC1954 cells and low-copy number NCI-H522 cells as well as Jurkat cells that do not express HER2 (Figure 3).